Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

45.09 +1.12 (+2.54%)

Streaming Delayed Price Updated: 12:02 PM EST, Jan 26, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	562,142
Open	43.21
Bid (Size)	45.02 (200)
Ask (Size)	45.17 (300)
Prev. Close	43.98
Today's Range	42.90 - 45.57
52wk Range	32.99 - 117.33
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Corcept Therapeutics Inc (NASDAQ:CORT) Fits the Affordable Growth Profile ↗

January 23, 2026

Via Chartmill

Why Did Corcept Therapeutics Stock Surge Over 14% Today? ↗

January 22, 2026

In the ROSELLA trial, patients receiving relacorilant with nab-paclitaxel saw their risk of death drop by about 35% compared with those given the chemotherapy alone.

Via Stocktwits

Performance

YTD	+18.0%	+18.0%
1 Month	-45.4%	-45.4%
3 Month	-37.9%	-37.9%
6 Month	-34.8%	-34.8%
1 Year	-25.2%	-25.2%

More News

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 22, 2026

Via Chartmill

Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer

January 22, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 Facing Headwinds

January 21, 2026

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

1 Safe-and-Steady Stock to Target This Week and 2 That Underwhelm

January 19, 2026

Via StockStory

Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – CORT

January 14, 2026

From DJS Law Group

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

Corcept Insider Transaction Explained After Shares Tumble 50% in One Day ↗

January 11, 2026

Via The Motley Fool

Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT)

January 09, 2026

From Scott+Scott Attorneys at Law LLP

Via Business Wire

CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Incorporated on Behalf of Corcept Stockholders and Encourages Investors to Contact the Firm

January 08, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm

January 07, 2026

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

1 Healthcare Stock to Target This Week and 2 We Turn Down

January 05, 2026

Via StockStory

CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

January 05, 2026

Via TheNewswire.com

CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

January 05, 2026

Via NewMediaWire

Why Corcept (CORT) Stock Is Trading Lower Today

January 05, 2026

Via StockStory

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

January 03, 2026

Via NewMediaWire

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

January 03, 2026

Via TheNewswire.com

In today's session, these stocks are experiencing unusual volume. ↗

January 02, 2026

Via Chartmill

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

January 02, 2026

Via NewMediaWire

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

January 02, 2026

Via TheNewswire.com

Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today ↗

January 02, 2026

Via Stocktwits

Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

January 01, 2026

Via StockStory

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 45.09

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 01/26/26 12:02 PM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 5.23B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.